[1]孙效棠,王万明,王辉,等.恶性肿瘤患者髋部骨折围术期血栓事件的对照研究[J].中华老年骨科与康复电子杂志,2018,(02):92-97.[doi:10.3877/cma.j.issn.2096-0263.2018.02.006]
 Sun Xiaotang,Wang Wanming,Wang Hui,et al.Comparative study of thrombotic events in hip fractures with/without therioma[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2018,(02):92-97.[doi:10.3877/cma.j.issn.2096-0263.2018.02.006]
点击复制

恶性肿瘤患者髋部骨折围术期血栓事件的对照研究()
分享到:

中华老年骨科与康复电子杂志[ISSN:1674-3911/CN:11-9292/R]

卷:
期数:
2018年02期
页码:
92-97
栏目:
深静脉血栓
出版日期:
2018-03-31

文章信息/Info

Title:
Comparative study of thrombotic events in hip fractures with/without therioma
作者:
孙效棠王万明王辉吕琦张志宏
350025 福州总医院骨二科
Author(s):
Sun Xiaotang Wang Wanming Wang Hui Lyu Qi Zhang Zhihong.
Department of orthopedics and traumatology, Fuzhou General Hospital, Fuzhou 350025, China
关键词:
髋骨折 血栓形成 肺栓塞 恶性肿瘤
Keywords:
Hip fractures Thrombosis Pulmonary embolism Therioma
DOI:
10.3877/cma.j.issn.2096-0263.2018.02.006
文献标志码:
A
摘要:
目的 探讨恶性肿瘤患者髋部骨折围术期发生血栓相关事件的风险。方法 采用回顾性对照研究的方法,收集2011年6月至2017年6月6年福州总医院收治的患有恶性肿瘤同时发生髋部骨折的患者资料作为研究组(肿瘤组),将同期发生的髋部骨折的非恶性肿瘤患者(一般骨折组)按照以下指标和权重与肿瘤组进行配对:(1)抗凝/抗血小板药物的使用;(2)基础疾病;(3)体重指数;(4)性别;(5)年龄,以增强两组间可比性。配对后采用Wilcoxon秩检验对比分析两组Caprini评分和术后血栓事件的累计分值。结果 6年间共筛查出患有恶性肿瘤的髋部骨折患者31例,因各类原因有22例进入肿瘤组。回顾筛查出非恶性肿瘤的髋部骨折患者1 020例,按照上述指标和权重筛选出22例作为一般骨折组与肿瘤组进行配对。两组Caprini评分肿瘤组明显高于一般骨折组(t=30.702,P=0.003)。肿瘤组术后DVT新发率为36.4%(8/22),术后PE发生率为22.8%(5/22),其中3名患者死亡。一般骨折组术后新发DVT为4.5%(1/22),无PE发生。VTE事件发生严重程度两组间有显著差异(t=50.211,P=0.012)。结论 恶性肿瘤患者髋部骨折围术期血栓事件的发生率明显高于一般的髋部骨折患者并且更为严重。
Abstract:
Objective To evaluate the risks of venous thrombosis events for the hip fracture patients with therioma. Methods A retrospective review and paired comparison was applied in this study, patients with hip fracture were retrieved between June 2011 through June 2017. Patients with hip fracture and therioma were included into the experimental group (therioma group) and patients with hip fracture but no therioma were included into fracture group and were matched with therioma group according to the following parameters and weight: (1) anticoagulant/antiplatelet medications; (2) underlying conditions; (3) body mass index; (4) gender; (5) age, aiming to increase the strength of comparison. Caprini score and accumulation score of venous thrombosis events after surgery were compared using Wilcoxon rank test. Results Thirty-one hip fractures with therioma were retrieved during 6 years, and 22 of them were qualified as therioma group. One thousand and twenty cases with hip fractures but without therioma were also retrieved, and 22 of them were selected and matched with the therioma group according to the above mentioned parameters and weight. These 22 cases were defined as the fracture group. As for the Caprini score, the therioma group was statistically higher than the fracture group (t=30.702, P=0.003). Incidence of DVT after surgery in the therioma group was 8/22 (36.4%) and incidence of PE was 5/22 (22.8%), 3 died. Incidence of DVT was 1/22 (4.5%) and no PE occurred in the fracture group. Altogether, incidence of VTE of two groups was statistically different (t=50.211, P=0.012). Conclusion Patients with hip fracture and therioma has significantly higher incidence of VTE and severity than those without therioma.

参考文献/References:

1 Olaf M, Cooney R. Deep venous thrombosis [J]. Emerg Med Clin North Am, 2017, 35(4): 743-770.
2 Engbers MJ, Blom JW, Cushman M, et al. Functional Impairment and Risk of Venous Thrombosis in Older Adults [J]. J Am Geriatr Soc, 2017, 65(9): 2003-2008.
3 邱贵兴, 杨庆铭, 余楠生, 等. 低分子肝素预防髋、膝关节手术后下肢深静脉血栓形成的多中心研究 [J]. 中华骨科杂志, 2006, 26(12): 819-822.
4 Robertson L, Yeoh SE, Stansby G, et al. Effect of testing for cancer on cancer-and venous thromboembolism(VTE)-related mortality and morbidity in People with unprovoked VTE [J]. Cochrane Database Syst Rev, 2017, 23(8): CD010837.
5 Farge D, Bounameaux H, Bauersachs RM, et al. Thrombosis,and cancer:a gender-specific analysis [J]. 2017, 151(Suppl 1): S21-S29.
6 Jara-Palomares L, Otero R, Jimenez D, et al. Development of a risk prediction score for occult cancer in patients with VTE [J]. 2017, 151(3): 564-571 .
7 Eichinger S. Cancer associated thrombosis: risk factors and outcomes [J]. Thromb Res, 2016, 140(S1): S12-S17.
8 Caprini JA. Risk assessment as a guide to thrombosis prophylaxis [J]. Curr Opin Pulm Med, 2010, 16(5): 448-452.
9 Luksameearunothai K, Sa-Ngasoongsong P, Kulachote N, et al. Usefulness of clinical predictors for preoperative screening of deep vein thrombosis in hip fractures [J]. BMC Musculoskelet Disord, 2017, 18 (1): 208.
10 何建国, 曾伟杰, 朱锋. 欧洲心脏病学会急性肺栓塞诊治指南解读 [J]. 中华医学杂志, 2009, 89(32): 2237-2239.
11 李晓强, 段鹏飞, 王深明. 2012版《深静脉血栓形成的诊断和治疗指南》解读 [J]. 中华医学杂志, 2013, 93(29): 2262-2263.
12 王新锋, 郭康, 李宁, 等. 比较恶性肿瘤与非恶性肿瘤静脉血栓患者肺栓塞发生率的差异 [J]. 中国实用医药, 2016, 11(14): 61-62.
13 Streiff MB, Agnelli G, Connors JM, et al. Guidance for the treatment of deep vein thrombosis and pulmonary embolism. J Thromb Thrombolysis. 2016;41(1):32-67.
14 Lee AY. Prevention and treatment of venous thromboembolism in patients with cancer. Hematology Am Soc Hematol Educ Program. 2014;2014(1):312-7.
15 Khorana AA, Kuderer NM, Culakova E, et al. Development and validation of a predictive model for chemotherapy-associated thrombosis [J]. Blood, 2008, 111(10): 4902-4907
16 Ay C, Dunkler D, Marosi C, et al. Prediction of venous thromboembolism in cancer patients [J]. Blood, 2010, 116(24): 5377-5382.
17 罗小云, 张福先, 张昌明, 等. 以下肢深静脉血栓形成为最初临床表现的恶性肿瘤病例分析 [J]. 中华普通外科杂志, 2013, 28(12): 935-937.
18 Redana S, Sharp A, Lote H, et al. Rates of major complications during neoadjuvant and adjuvant chemotherapy for early breast cancer: An off study population [J]. Breast, 2016, 30: 13-18.
19 Hsu A, Belkin E, Han S, et al. Tamoxifen-associated portal vein thrombosis causing severe oesophageal variceal bleeding [J]. BMJ Case Rep, 2015, 27: 2015.
20 Adesanya MA, Maraveyas A, Madden LA. Cancer microvesicles induce tissue factor-related procoagulant activity in endothelial cells in vitro [J]. Blood Coagul Fibrinolysis, 2017, 28(5): 365-372.
21 Rautou PE, Mackman N. Microvesicles as risk markers for venous thrombosis [J]. Expert Rev Hematol, 2013, 6(1): 91-101.

相似文献/References:

[1]吴斗,郝海虎,朱剑,等.老年髋部骨折术后谵妄的危险因素分析[J].中华老年骨科与康复电子杂志,2015,(01):34.
[2]姬晨妮,陈伟,朱燕宾,等.京津唐地区1 583例老年股骨转子间骨折流行病学特征分析[J].中华老年骨科与康复电子杂志,2015,(01):45.
[3]裴宝瑞,吴啸波,李力更,等.应用低分子肝素钙预防老年髋部骨折术前静脉血栓栓塞症的剂量研究[J].中华老年骨科与康复电子杂志,2016,(02):76.[doi:10.3877/cma.j.issn.2096-0263.2016.02.003]
 Pei Baorui,Wu Xiaobo,Li Ligeng,et al.The efficacy of low molecular weight heparin calcium of preventive versus therapeutic dose in prevention of venous thromboembolism in elderly patients before hip fracture surgery[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2016,(02):76.[doi:10.3877/cma.j.issn.2096-0263.2016.02.003]
[4]钟俊青,王连成.快速外科通道理念对老年股骨转子间骨折围手术期康复指导的前瞻性研究[J].中华老年骨科与康复电子杂志,2016,(02):87.[doi:10.3877/cma.j.issn.2096-0263.2016.02.005]
 Zhong Junqing,Wang Liancheng..Prospective study of the effect of fast track surery on peri-operative rehabilitation of elderly intertrochanteric fracture[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2016,(02):87.[doi:10.3877/cma.j.issn.2096-0263.2016.02.005]
[5]吴啸波,裴宝瑞.老年髋部骨折围手术期相关问题的研究进展[J].中华老年骨科与康复电子杂志,2016,(02):114.[doi:10.3877/cma.j.issn.2096-0263.2016.02.010]
 Wu Xiaobo,Pei Baorui..Perioperative related problems of surgery in elderly patients with hip fractures[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2016,(02):114.[doi:10.3877/cma.j.issn.2096-0263.2016.02.010]
[6]张静,李志锐,唐佩福.老年粗隆间骨折的手术治疗进展[J].中华老年骨科与康复电子杂志,2016,(04):250.[doi:10.3877/cma.j.issn.2096-0263.2016.04.011]
 Li Zhirui,Zhang Jing,Tang Peifu.Progress of surgical treatment for femoral intertrochanteric fracture in the elderly patients[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2016,(02):250.[doi:10.3877/cma.j.issn.2096-0263.2016.04.011]
[7]侯建伟,谢仁国,李玉前,等.加长型 PFNA-Ⅱ和DHS治疗老年骨质疏松性股骨转子下骨折的疗效分析[J].中华老年骨科与康复电子杂志,2017,(01):22.[doi:10.3877/cma.j.issn.2096-0263.2017.01.005]
 Hou Jianwei,Xie Renguo,Li Yuqian,et al.Clinical effective analysis of lengthened PFNA- II fixation and dynamic hip screw for senile osteoporotic subtrochanteric fractures[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2017,(02):22.[doi:10.3877/cma.j.issn.2096-0263.2017.01.005]
[8]常晓,张保中,翁习生,等.高龄髋部骨折术后院内死亡的危险因素分析[J].中华老年骨科与康复电子杂志,2017,(01):43.[doi:10.3877/cma.j.issn.2096-0263.2017.01.009]
 Chang Xiao,ZhangBaozhong,WengXisheng,et al.Risk factor analysis for postoperative mortality in hospital of geriatric hip fracture patients[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2017,(02):43.[doi:10.3877/cma.j.issn.2096-0263.2017.01.009]
[9]于沂阳,李石伦,陈伟,等.中国北方和南方地区 2010—2011年 60岁以上人群股骨转子间骨折流行病学对比[J].中华老年骨科与康复电子杂志,2017,(01):55.[doi:10.3877/cma.j.issn.2096-0263.2017.01.011]
 Yu Yiyang,Li Shilun,Chen Wei,et al.Epidemiological comparison of geriatric intertrochanteric fractures between north and south areas of China from 2010 to 2011[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2017,(02):55.[doi:10.3877/cma.j.issn.2096-0263.2017.01.011]
[10]徐进,李平,马信龙.老年髋部骨折手术快通道化变革中的麻醉管理[J].中华老年骨科与康复电子杂志,2017,(01):59.[doi:10.3877/cma.j.issn.2096-0263.2017.01.012]
 Xu Jin,Li Ping,Ma Xinlong.Anesthetic management of immediate reparative surgery in elderly patients with hip fractures[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2017,(02):59.[doi:10.3877/cma.j.issn.2096-0263.2017.01.012]

备注/Memo

备注/Memo:
基金项目:南京军区面上项目(15MS132)
更新日期/Last Update: 2018-03-27